Undisclosed pharmaceutical industry ties are common among endocrinologist ‘key opinion leaders’ who hold leadership positions in diabetes organisations, an Australian study has found. Industry fees averaging $10,702 (range $2638–$28,744) were made to 24 of 33 endocrinologists who held positions with professional medical groups between 205 and 2018, according to an analysis by Sydney University researchers. ...
Endocrinologists’ $10k fees from industry raise concerns over conflict of interest
9 Mar 2020